← Back to all trials
Completed
NCT07639034
Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease
Conditions: Dry Eye Disease (DED)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 33
Sponsor: Gordon Schanzlin New Vision
Location: Gordon Schanzlin New Vision Institute La Jolla California
Summary
The primary objective of this study is to show that consistent use of Systane PRO over a 30 period will significantly improve the signs and symptoms of Dry Eye Disease and decrease patients' ocular surface disease index score for patients diagnosed with mild-moderate (DED).
Eligibility Criteria
Inclusion Criteria:
* Patients aged 18 and older with mild-moderate DED (as determined by an OSDI score between 13-22).
Exclusion Criteria:
* Patients unwilling to discontinue all concomitant ophthalmic medications and dry eye therapies for the duration of the study.
Source: ClinicalTrials.gov (NCT07639034). StuddyBuddy aggregates publicly available trial information.
